Standard Chartered Plans to Reduce Corporate Functions Workforce by Over 15 in Pursuit of Higher Returns Fed Rate Hike Expectations Surge After Inflation Data Market Ponders December Move SpaceX Delays Starship Launch as Company Prepares for Landmark Share Sale Wall Street Analysts Weigh In on Air Products and Chemicals What Does the Consensus Suggest Gold Price Outlook 2026 Analysts Weigh Potential Trajectory Amid Economic Uncertainty Traders Bet on IonQ Micron and Anduril as Next Potential US Government Stake Targets Prime Medicine Inc PRME Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Development Phase KEQU Q1 2026 Earnings EPS of 028 Reported Stock Edges Lower in Light Trading SVC Q1 2026 Earnings Substantial EPS Miss Amid Operational Headwinds USPH Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment Despite Operational Consistency YQ Q3 2025 Earnings Significant perShare Loss Clouds NearTerm Visibility Everest Group EG Q1 2026 Earnings Strong EPS Beat Amid Resilient Underwriting Results FG Nexus Inc FGNX Slides 186 as Key Support Levels Come into Focus Ascentage Pharma AAPG Advances 22 as Biotech Sector Finds Footing First US Bancshares FUSB Edges Lower as Stock Nears Key Support Level DLocal Limited DLO Slips as Shares Test Key Support at 1102 Incyte Corp INCY Edges Lower as Stock Consolidates Near Key Levels Live Music Spending Sees Shift as Consumers Become More Intentional With Concert Choices Iovance Biotherapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Momentum Civista Bancshares CIVB Holds Steady Near Support After Minor Decline Cantor Equity Partners I Inc CEPO Edges Higher as Stock Consolidates Near Key Levels Sentage Holdings SNTG Holds Steady at 200 as Trading Range Narrows Genius Group GNS Slips 327 as Shares Test Critical Support Near 022 Parke Bancorp PKBK Edges Higher Support Holds as Stock Approaches Key Resistance Gain Therapeutics GANX Bounces Back Testing Key Resistance at 187 PennyMac Mortgage Investment Trust PMT Inches Higher as It Tests Resistance IN8bio Edges Lower as Biotech Sector Faces Headwinds